In vitro efficacy of a 0.2% polyhexamethylene biguanide-impregnated gauze dressing against pathogenic bacterial isolates found in horses.

Summary

# Editorial Summary: PHMB-impregnated gauze efficacy against equine wound pathogens Researchers evaluated whether 0.2% polyhexamethylene biguanide (PHMB)-impregnated gauze dressings could inhibit growth of bacteria commonly isolated from equine wounds, joint infections and hoof injuries by culturing nine clinical isolates plus two reference strains on agar plates and measuring bacterial growth inhibition under treated versus untreated gauze squares after 24 hours. The PHMB dressing demonstrated variable but meaningful activity against Staphylococcus species (33–83% growth inhibition) and E. coli (6.5–37% inhibition), yet proved ineffective against Pseudomonas aeruginosa and Enterococcus species—a finding of clinical significance given the prevalence of these latter pathogens in equine septic conditions. Whilst the in vitro model's limitations mean results cannot be directly extrapolated to clinical practice, the differential antimicrobial spectrum warrants further investigation through controlled in vivo studies to establish whether PHMB dressings might usefully complement conventional management of equine penetrating wounds and soft tissue infections. Practitioners should note that this dressing's effectiveness appears strain-dependent rather than universal, suggesting its role may be most appropriate for infections where Staphylococcus or E. coli predominate, rather than as a broad-spectrum antimicrobial solution for all equine wound types.

Read the full abstract on PubMed

Key Findings

• •0.2% PHMB-impregnated gauze inhibited Staphylococcus spp. growth by 33-83.1% compared to control gauze
• •The same dressing inhibited E. coli spp. growth by only 6.5-37%
• •No inhibition was observed against Pseudomonas aeruginosa or Enterococcus spp.
• •Efficacy varied substantially between bacterial strains within the same species

Conditions Studied